Hertfordshire Partnership University NHS Foundation Trust

Psyomics specializes in the development of proteomic diagnostics aimed at improving early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers web-based assessment triage designed to facilitate diagnostic and pathway prediction for mental health conditions. By integrating digital profiling with cutting-edge biological research, Psyomics enhances diagnostic accuracy and supports primary care practitioners in effectively managing their patients' mental health needs. This innovative approach digitally replicates a psychiatric assessment at the initial point of contact, thereby enabling patients to achieve better recovery outcomes from mental health disorders.